Sana Biotechnology (SANA) Current Assets (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Current Assets data on file, last reported at $111.7 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 0.92% year-over-year to $111.7 million; the trailing twelve-month figure through Mar 2026 stood at $111.7 million (down 0.92% YoY), and the FY2025 full-year result was $148.7 million, down 7.54% from the prior year.
• Current Assets declined to $111.7 million in Q1 2026, from $148.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $523.2 million in Q1 2022 to a low of $82.5 million in Q2 2025.
• A 5-year average of $278.6 million and a median of $263.5 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets plunged 68.68% in 2025 and slipped 0.92% in 2026, its largest moves.
• Tracing SANA's Current Assets over 5 years: stood at $444.4 million in 2022, then plunged by 51.96% to $213.5 million in 2023, then fell by 24.69% to $160.8 million in 2024, then retreated by 7.54% to $148.7 million in 2025, then decreased by 24.88% to $111.7 million in 2026.
• Business Quant data shows SANA's Current Assets at $111.7 million in Q1 2026, $148.7 million in Q4 2025, and $161.8 million in Q3 2025.